3 months on oral finasteride/minoxidil – early progress? Progress Pictures 11/25/2025
A 28-year-old male is documenting his early progress with oral finasteride (1mg daily) and oral minoxidil (2.5mg daily) for hair loss, noting some improvement after three months. He also uses supplements, head massages, and a derma roller, with no significant side effects reported.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 6 months oral Fin 1mg + Min 3mg
A 36-year-old shared their 6-month progress using 1mg oral finasteride, 3mg oral minoxidil, and other treatments like tretinoin cream and microneedling for hair regrowth. They experienced side effects like watery semen and puffy eyes, which improved with supplements, and reported increased happiness and motivation.
community Almost 3 months on Minoxidil and Finasteride
A 31-year-old man experienced significant hair regrowth after nearly three months of using oral Minoxidil (3 mg) and Finasteride (1 mg), along with derma rolling, Biotin, and other supplements. He reports no noticeable side effects and encourages others to try the treatment.
community I’m 42 and this is an 80 day update on my current hair treatment. Taking oral finasteride and minoxidil plus topical minoxidil.
A 42-year-old is experiencing hair regrowth after 80 days using oral finasteride and minoxidil, plus topical minoxidil. They are considering additional treatments like dermastamping and possibly switching to dutasteride for further improvement.
community No longer need a hat to leave the house. Praise Jesus. 12 months progress. 24 years old.
A 24-year-old shared his 12-month hair loss progress, using 1mg oral finasteride daily, Minoxidil spray twice daily, weekly derma stamping, daily Biotin, Saw Palmetto Shampoo, and occasional Ketoconazole shampoo. He experienced minimal side effects and significant hair density improvement, no longer needing a hat.
community 14 months into fin + min and my hair is way worse than before
The user experienced worsening hair loss despite using finasteride, minoxidil, and microneedling. Suggestions included reducing microneedling frequency, switching to oral minoxidil, adding tretinoin, and considering dutasteride.
Related Research
6 / 6 resultsresearch Oral Presentations
This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.
research Phytochemicals as emerging therapeutic agents for alopecia treatment
This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
research Abstracts
This review discusses autoimmune blistering diseases across species and highlights new treatment efficacy findings and ongoing trials, but it reports no new clinical results.
research Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
This review discusses the combined use of plum-blossom and Daoma needle therapy for androgenic alopecia, emphasizing its potential benefits and the need for further clinical research, but reports no new results.
research Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives
This review explores the potential of metal nanoparticles as innovative treatments for alopecia, highlighting their effectiveness in promoting hair regrowth, enhancing drug delivery, and modulating gene expression while also assessing the related experimental methodologies and regulatory considerations.
research A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
This review discusses current topical treatments, natural products, and complementary therapies for androgenetic alopecia, but it reports no new clinical results.